Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02754037 · ClinicalTrials.gov registry record

Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study

A clinical trial of Non-alcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD), sponsored by University of California, Davis.

Active
Registry status
120
Enrollment target
1
Study location

NCT02754037 is a study of Non-alcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 120 participants, below the 157-participant average among 8 other Non-alcoholic Steatohepatitis (NASH) trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02754037, a study of Non-alcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD), is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate non-invasive imaging techniques for determining liver steatosis (fat), inflammation (abnormal tissue swelling), and fibrosis (abnormal tissue scarring).In addition, the study group will be using other test measures including personal demographics, laboratory blood test results, and imaging measurements to determine the severity of NAFLD (non-alcoholic fatty liver disease), NASH (non-alcoholic steatohepatitis), inflammation, and fibrosis.

Conditions Studied

Non-alcoholic Steatohepatitis (NASH) Non-Alcoholic Fatty Liver Disease (NAFLD)

Interventions

  • RADIATION Fluorodeoxyglucose (FDG) positron emission tomography (PET)
  • OTHER Magnetic resonance imaging (MRI)
  • RADIATION PET Explorer

Study Locations (1)

California

  • University of California Davis Medical Center - Sacramento

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2016-04-30
Est. Completion 2026-06-30

Sponsor

University of California, Davis

657 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02754037

The ClinicalTrials.gov registry entry for NCT02754037 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 157-participant average among 8 other Non-alcoholic Steatohepatitis (NASH) trials with a reported enrollment target (24% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Non-alcoholic Steatohepatitis (NASH) appearing as the primary indexed condition, and to 3 interventions - of which Fluorodeoxyglucose (FDG) positron emission tomography (PET) is the first listed.

NCT02754037 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02754037 about?

NCT02754037 is a clinical study titled "Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study". The goal of this study is to evaluate non-invasive imaging techniques for determining liver steatosis (fat), inflammation (abnormal tissue swelling), and fibrosis (abnormal tissue scarring).In addition, the study group will be using other test measures including personal demographics, laboratory blo...

What is the current status of trial NCT02754037?

This trial is currently active not recruiting. The enrollment target is 120 participants. The study started on 2016-04-30. Estimated completion is 2026-06-30.

What conditions does trial NCT02754037 study?

This clinical trial studies the following conditions: Non-alcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease (NAFLD).

What interventions are being tested in trial NCT02754037?

The interventions under investigation include: Fluorodeoxyglucose (FDG) positron emission tomography (PET) (RADIATION), Magnetic resonance imaging (MRI) (OTHER), PET Explorer (RADIATION).

Who is sponsoring clinical trial NCT02754037?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02754037 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Non-alcoholic Steatohepatitis (NASH)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Non-alcoholic Steatohepatitis (NASH)

All registered trials for this condition

Non-Alcoholic Fatty Liver Disease (NAFLD)

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.